C. Joseph Ross Daval

C. Joseph Ross Daval, J.D.

Submitted by on Fri, 12/22/2023 - 17:09
C. Joseph Ross Daval, J.D. is a research fellow at the Program on Regulation, Therapeutics, and Law (PORTAL), at Brigham & Women’s Hospital and Harvard Medical School. His work has appeared in JAMA, the New England Journal of Medicine, and Health Affairs, and examines how prescription drug

Building Public Trust in Scientific Decision Making through Expert Advisory Committees

Submitted by on Fri, 12/22/2023 - 16:41

When faced with difficult decisions about new drugs or medical devices, the Food and Drug Administration (FDA) is authorized to consult with advisory committees of independent experts. Advisory committees provide critical scientific insights and credibility for FDA efficacy and safety determinations.

Research Fellow, Program on Regulation, Therapeutics, and Law
Brigham & Women’s Hospital and Harvard Medical School
617-278-0930

jrdaval@gmail.com

C. Joseph Ross Daval, J.D. is a research fellow at the Program on Regulation, Therapeutics, and Law (PORTAL), at Brigham & Women’s Hospital and Harvard Medical School. His work has appeared in JAMA, the New England Journal of Medicine, and Health Affairs, and examines how prescription drug policy is shaped by federal laws and regulations, covering topics such as FDA’s use of advisory committees, misconduct in the pharmaceutical industry, and Medicare’s authority to shape drug coverage. Joseph received a J.D. from Yale Law School, where he served as an editor on the Yale Law Journal, and a codirector of the HAVEN Medical-Legal Partnership, which connected uninsured New Haven residents with legal assistance. He has held summer positions at the National Immigration Law Center and the Chambers of the President of the Supreme Court of Israel.